Multidimensional progressive single-cell sequencing reveals cell microenvironment composition and cancer heterogeneity in lung cancer

被引:2
作者
Chen, Hua [1 ,2 ]
Song, Anqi [3 ]
UL Rehman, Faisal [4 ]
Han, Dan [5 ]
机构
[1] Qingdao Bioman Biomed Technol Co LTD, Dept Res & Dev, Qingdao, Peoples R China
[2] Shanghai life Biomed Technol Co LTD, Dept Res & Dev, Shanghai, Peoples R China
[3] Harbin Med Univ, Affiliated Hosp 2, Dept Student Affairs, Harbin, Peoples R China
[4] Qingdao Univ, Affiliated Hosp, Precis Med Ctr Oncol, Qingdao, Peoples R China
[5] Shanghai Songjiang Dist Cent Hosp, Dept Emergency Med & Intens Care, Shanghai, Peoples R China
关键词
biomarkers; lung cancer; single-cell sequencing; tumor heterogeneity; tumor microenvironment; SURFACTANT PROTEIN-B; INTRATUMOR HETEROGENEITY; TUMOR HETEROGENEITY; EVOLUTION; STATISTICS; BIOMARKER;
D O I
10.1002/tox.24018
中图分类号
X [环境科学、安全科学];
学科分类号
08 ; 0830 ;
摘要
Despite substantial advances in cancer biology and treatment, the clinical outcomes of patients with lung cancer remain unsatisfactory. The tumor microenvironment (TME) is a potential target. Using single-cell RNA sequencing, we could distinguish eight distinct cell types in the lung cancer microenvironment, demonstrating substantial intratumoral heterogeneity in 19 different lung cancer tumor samples. Through the re-dimensional grouping of cancer-associated fibroblasts (CAFs), myeloid cells, epithelial cells, natural killer (NK) cells, and T cells, the difference in the TME of lung cancer was revealed. We discovered SFTPB, SFN, and KRT8 as possible predictive biomarkers for lung cancer by assessing the gene expression patterns in epithelial cells. Examining cell-to-cell communications showed a robust association between the quantity of matrix CAFs, epithelial cells, and macrophages in the thrombospondin signaling pathway. Additionally, we found that the amyloid precursor protein signaling pathway primarily originated from the matrix, and inflammatory cancer-associated endothelial and fibroblast cells showed a co-expression relationship with myeloid cells and B cells. Through cell-to-cell correlation analysis, we found positive regulation between NK cells, regulatory T cells, GZMB-CD8 T cells, and GZMK-CD8 T cells, which could play a role in developing immune TMEs. These findings support studies on cancer heterogeneity and add to our understanding of lung cancer's cellular microenvironment.
引用
收藏
页码:890 / 904
页数:15
相关论文
共 56 条
  • [1] Toward understanding and exploiting tumor heterogeneity
    Alizadeh, Ash A.
    Aranda, Victoria
    Bardelli, Alberto
    Blanpain, Cedric
    Bock, Christoph
    Borowski, Christine
    Caldas, Carlos
    Califano, Andrea
    Doherty, Michael
    Elsner, Markus
    Esteller, Manel
    Fitzgerald, Rebecca
    Korbel, Jan O.
    Lichter, Peter
    Mason, Christopher E.
    Navin, Nicholas
    Pe'er, Dana
    Polyak, Kornelia
    Roberts, Charles W. M.
    Siu, Lillian
    Snyder, Alexandra
    Stower, Hannah
    Swanton, Charles
    Verhaak, Roel G. W.
    Zenklusen, Jean C.
    Zuber, Johannes
    Zucman-Rossi, Jessica
    [J]. NATURE MEDICINE, 2015, 21 (08) : 846 - 853
  • [2] Cellular Heterogeneity and Molecular Evolution in Cancer
    Almendro, Vanessa
    Marusyk, Andriy
    Polyak, Kornelia
    [J]. ANNUAL REVIEW OF PATHOLOGY: MECHANISMS OF DISEASE, VOL 8, 2013, 8 : 277 - 302
  • [3] Reference-based analysis of lung single-cell sequencing reveals a transitional profibrotic macrophage
    Aran, Dvir
    Looney, Agnieszka P.
    Liu, Leqian
    Wu, Esther
    Fong, Valerie
    Hsu, Austin
    Chak, Suzanna
    Naikawadi, Ram P.
    Wolters, Paul J.
    Abate, Adam R.
    Butte, Atul J.
    Bhattacharya, Mallar
    [J]. NATURE IMMUNOLOGY, 2019, 20 (02) : 163 - +
  • [4] Lung Cancer 2020 Epidemiology, Etiology, and Prevention
    Bade, Brett C.
    Dela Cruz, Charles S.
    [J]. CLINICS IN CHEST MEDICINE, 2020, 41 (01) : 1 - +
  • [5] Suppression of natural killer cell-mediated bone marrow cell rejection by CD4+CD25+ regulatory T cells
    Barao, I
    Hanash, AM
    Hallett, W
    Welniak, LA
    Sun, K
    Redelman, D
    Blazar, BR
    Levy, RB
    Murphy, WJ
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2006, 103 (14) : 5460 - 5465
  • [6] Distinct evolutionary trajectories of primary high-grade serous ovarian cancers revealed through spatial mutational profiling
    Bashashati, Ali
    Ha, Gavin
    Tone, Alicia
    Ding, Jiarui
    Prentice, Leah M.
    Roth, Andrew
    Rosner, Jamie
    Shumansky, Karey
    Kalloger, Steve
    Senz, Janine
    Yang, Winnie
    McConechy, Melissa
    Melnyk, Nataliya
    Anglesio, Michael
    Luk, Margaret T. Y.
    Tse, Kane
    Zeng, Thomas
    Moore, Richard
    Zhao, Yongjun
    Marra, Marco A.
    Gilks, Blake
    Yip, Stephen
    Huntsman, David G.
    McAlpine, Jessica N.
    Shah, Sohrab P.
    [J]. JOURNAL OF PATHOLOGY, 2013, 231 (01) : 21 - 34
  • [7] Human tumor-induced and naturally occurring Treg cells differentially affect NK cells activated by either IL-2 or target cells
    Bergmann, Christoph
    Wild, Clarissa A.
    Narwan, Mustafa
    Lotfi, Ramin
    Lang, Stephan
    Brandau, Sven
    [J]. EUROPEAN JOURNAL OF IMMUNOLOGY, 2011, 41 (12) : 3564 - 3573
  • [8] Molecular biomarkers for lung adenocarcinoma
    Calvayrac, Olivier
    Pradines, Anne
    Pons, Elvire
    Mazieres, Julien
    Guibert, Nicolas
    [J]. EUROPEAN RESPIRATORY JOURNAL, 2017, 49 (04)
  • [9] Changing profiles of cancer burden worldwide and in China: a secondary analysis of the global cancer statistics 2020
    Cao, Wei
    Chen, Hong-Da
    Yu, Yi-Wen
    Li, Ni
    Chen, Wan-Qing
    [J]. CHINESE MEDICAL JOURNAL, 2021, 134 (07) : 783 - 791
  • [10] Analysis of 100,000 human cancer genomes reveals the landscape of tumor mutational burden
    Chalmers, Zachary R.
    Connelly, Caitlin F.
    Fabrizio, David
    Gay, Laurie
    Ali, Siraj M.
    Ennis, Riley
    Schrock, Alexa
    Campbell, Brittany
    Shlien, Adam
    Chmielecki, Juliann
    Huang, Franklin
    He, Yuting
    Sun, James
    Tabori, Uri
    Kennedy, Mark
    Lieber, Daniel S.
    Roels, Steven
    White, Jared
    Otto, Geoffrey A.
    Ross, Jeffrey S.
    Garraway, Levi
    Miller, Vincent A.
    Stephens, Phillip J.
    Frampton, Garrett M.
    [J]. GENOME MEDICINE, 2017, 9